Distributore ufficiale ZOLL da 30 anni

Golden Hour Data Systems, Inc. acquired. Accelerates patient charting and revenue cycle management to the EMS market.

ZOLL honored for world class excellence in customer satisfaction for eighteenth consecutive year, the only company to receive this distinction.

ZOLL introduces µCor™ (pronounced "Micro Core") Heart Failure and Arrhythmia Management System (HFAMS), new technology to improve the management of acute heart failure patients. First commercial patient prescribed with the system.

ZOLL acquires TherOx, Inc., which offers SSO2 Therapy, a new FDA-approved treatment to help the most severe heart attack patients. SSO2 Therapy infuses super oxygenated blood to improve microvascular flow and restore heart tissue to normal oxygen level.

ZOLL acquires Mobilize Rescue Systems. Offers interactive trauma system to help bystanders save lives during medical emergencies.

ZOLL rebrands Payor Logic solution as ZOLL AR Boost; better reflects the potential impact of this technology on a wider segment of the healthcare market.

2018
Propaq® M selected by U.S. Air Force and U.S. Army as their deployable vital signs monitor

ZOLL first company to receive premarket approval from the FDA on its full portfolio of defibrillators

Three ZOLL Medical/Bio-Detek employees help save a co-worker's life using an AED and electrodes made by the company

VEST trial shows LifeVest wearable defibrillator reduces total mortality by 36% at 90 days

Singapore awards ZOLL save-a-life initiative to install 5,000 AED Plus units in public housing

Heroes for Life program launched to honor "unexpected heroes" who have helped save the life of a sudden cardiac arrest victim with a ZOLL AED. Program also recognizes SCA survivors.

Respond™ app introduced to improve communication and navigation among EMS dispatchers, crews, and clinical staff.

Z Vent™ transport ventilator for pre- and intra-hospital use introduced. Offers full range of ventilation options and is easy to use.

Air-Glaciers, a Swiss helicopter company, standardizes on ZOLL's lifesaving equipment for its aircraft.

ZOLL scores Gold Level recognition from the American Heart Association (AHA) for Workplace Health Achievement.

2017

ZOLL honored for the 16th consecutive year for excellence in customer satisfaction; only company to achieve the 16-year distinction.

ZOLL Hospital Wearable Defibrillator (HWD) receives premarket approval from the FDA.

2016

ZOLL receives market approval for intravascular temperature management technology to treat sudden cardiac arrest in Japan.

ZOLL honored for the 15th consecutive year for excellence in customer satisfaction.

Eleven caregivers awarded the ZOLL EMT Scholarship in the program's inaugural year.

2015

Dubai Police Department equips its fleet of luxury and regular patrol cars with the AED Plus®

ZOLL ResQCPR System receives premarket approval from the FDA; shown to profoundly increase blood flow to the heart and other vital organs in pre-clinical studies.

2014

Achieves platinum status as an AHA Fit-Friendly Company for third consecutive year

Hosts first Dubai Sudden Cardiac Arrest Symposium for United Arab Emirate countries

Singapore Armed Forces standardizes on the Propaq® MD

Wins 13th consecutive NorthFace ScoreBoard AwardSM for excellence in customer satisfaction

Expands product portfolio to include ventilation with the acquisition of assets of Impact Instrumentation, Inc., of West Calwell, N.J.

RescueNet ePCR achieves NEMSIS Version 3 compliance

Acquires Philips InnerCoolTM temperature management business

2013

Receives Shonin approval to market intravascular temperature management (IVTM™) technology in Japan

Introduces the Fully Automatic AED Plus®, first fully automatic AED with Real CPR Help®

Study reports survival from sudden cardiac arrest more than doubles with ZOLL CPR feedback technology and resuscitation training

Wins patent infringement case against ELan Med GmbH

Wins 12th consecutive NorthFace ScoreBoard Awards for excellence in customer satisfaction

2012

X Series™ Monitor/Defibrillator receives 510(k) marketing clearance from the FDA.

Asahi Kasei acquires ZOLL for $2.21 billion.

ZOLL introduces the first pediatric electrodes that report CPR quality on young children up to eight years of age.

ZOLL establishes new Japanese subsidiary Asahi Kasei ZOLL Medical (AZM).

ZOLL IVTM™ successfully revives 17 pilgrims from heat stroke during Hajj 2012.

2011

ZOLL receives Frost & Sullivan 2010 Market Leadership Award for demonstrated excellence in capturing the highest market share the North American external defibrillator market.

Physician prescriptions for ZOLL LifeVest top 35,000.

PocketCPR® FOR iPhone training app first to support new 2010 AHA/ERC/ILCOR Guidelines.

ZOLL launches iPad app for ePCR; EMS teams can now use iPad technology to complete electronic patient care reports.

Australia's NSW Rural Fire Service, world's largest volunteer fire fighting agency, orders more than 5,000 AED Plus units for state wide initiative.

ZOLL honored with 10th successive Omega NorthFace ScoreBoard Award℠ for excellence in technical support and customer service.

Welsh Ambulances NHS Trust awards ZOLL largest contract to date for the E Series in the U.K.

ZOLL reports record second quarter revenue and earnings.

ZOLL reports record Q4 and annual revenues; Breaks the $500 million mark with fiscal 2011 revenues of $523.7 million.

2010

Propaq® MD monitor/defibrillator and Propaq M monitor granted 510(k) clearance by the FDA

Brazil Ministry of Health awards ZOLL AED contract for the country's public EMS system.

ZOLL LifeVest® Wearable Defibrillator physician prescriptions top 30,000.

ZOLL LifeVest Wearable Defibrillator prescribed by physicians at all U.S. News and World Report "Honor Roll Hospitals" for third consecutive year.

ZOLL's resuscitation technology strongly aligned with the new AHA/ERC/ILCOR 2010 Guidelines' emphasis on high-quality CPR and minimizing interruptions in chest compressions.

Swiss Air Rescue, Rega, the first international installation, and PHI Air Medical of Phoenix, Arizona, the first North American installation, of the ultra lightweight Propaq MD Monitor/Defibrillator.

Nine SCA survivors saved with the help of ZOLL devices among 50 survivors selected to attend 50th anniversary of CPR celebration in San Diego.

2009

ZOLL is one of only ten companies on Forbes Top 100 Most Trustworthy Companies list for all three years of its publication.

LifeVest wearable defibrillator prescribed by doctors at all U.S. Honor Roll Hospitals.

ZOLL purchases intravascular temperature management (IVTM™)assets from Alsius Corporation.

New R Series BLS and R Series Plus receive FDA clearance.

2008

First hands-only CPR AED Plus

STEMI solutions offer enhanced transmission technology for 12-lead EKG.

AED Pro receives airworthy designation.

RescueNet® ePCR suite designated NEMSIS Gold Compliant Software.

AutoPulse approved for use in China.

LifeVest Wearable Defibrillator exceeds 10,000 prescriptions.

R Series Code-Ready® defibrillator awarded highest value score in the U.K.

ZOLL and Welch Allyn enter strategic alliance; ZOLL becomes exclusive distributor of Propaq® LT.

ZOLL has record annual results. Reaches $398 million in revenues; up 29 percent over previous year.

2007
ZOLL receives market clearance for E Series® with Real CPR Help® technology.

ZOLL receives clearance to market E Series with See-Thru CPR® technology; functionality helps minimize interruptions in CPR.

ZOLL named one of Forbes Most Trustworthy companies in America for the first time.

ZOLL purchases the temperature management assets of Radiant Corporation.

ZOLL receives clearance to market AED Pro with See-Thru CPR technology; helps minimize interruptions in CPR.

ZOLL surpasses $300 million mark in revenues.

2006

ZOLL launches the R Series®, the first and only "Code-Ready®" defibrillator for hospitals.

2005

ZOLL launches the E Series®, ZOLL's newest defibrillator designed to meet the specific demands and extreme conditions of the EMS environment (temperature, moisture, and portability).

2004

Renames its Pinpoint Technologies subsidiary ZOLL Data Systems® to better reflect the EMS market.

Acquires Infusion Dynamics, Inc., which manufactures a unique fluid resuscitation product called the Power Infuser®.

Pediatric capability for the ZOLL AED Plus receives 510(k) marketing clearance from the FDA.

Launches CodeNet®, the first complete data management system that solves the problem of hard-to-manage code event data for hospitals.

2003

Enters into an agreement with Revivant Corporation to commercialize the AutoPulse® Non-invasive Cardiac Support Pump, a new FDA-approved portable device that automates chest compressions, and increases blood flow to the brain and heart more consistently than manual CPR.

The AED Plus wins First Place in Product Design and Development magazine's prestigious 2003 Engineering Awards Program.

2002

ZOLL provides an initial grant to help establish the AED Instructor Foundation.

The M Series CCT is selected as the defibrillator of choice for the U.S. Military Patient Movement Item Program. The agreement, worth $8.9 million, is the single largest order in ZOLL's history.

ZOLL and LIFECOR, Inc. announce an agreement to sell LIFECOR's LifeVest Wearable Defibrillator to hospitals for patient use in the United States and Canada.

2001

Launches the M Series® CCT for critical care transport.

The ZOLL AED Plus® is designed in cooperation with the Burlington, Mass. Police Department and hundreds of other first responders and EMS agencies.

1999

Announces the revolutionary Rectilinear Biphasic™ defibrillation waveform, which lowers the energy needed for successful defibrillation and cardioversion. In a unique development, the FDA clears ZOLL's new biphasic waveform to be labeled as clinically superior to monophasic defibrillators for the conversion of ventricular fibrillation in high-impedance patients and for cardioversion of atrial fibrillation. ZOLL is the first company to have FDA clearance to make such superiority claims since the development of defibrillation in the 1950s.

Acquires Pinpoint Technologies to provide a complete information management solution to the EMS market.

Introduces "Smart Batteries," an industry first. Smart Batteries provide users with accurate run times directly displayed on the battery. This development eliminates time-consuming testing procedures and minimizes user error.

1998
Introduces the M Series®, the most advanced defibrillator worldwide. The product weighs 11 pounds, and is approximately one third the size and half the weight of any competitive full-featured defibrillator. The M Series is the first to provide a bright, high-contrast display of cardiac rhythms, a critical capability for any emergency unit.

1997

Unveils a tablet computer-based 12-lead system to help identify the onset of cardiac arrest.

1996

Makes an equity investment in LIFECOR, Inc., a medical equipment company that makes the LifeVest®, the first and only wearable defibrillator.

Introduces the ZOLL 1700, the first fully integrated AED/manual external defibrillator for hospital BLS and ACLS use.

Announces the new Base PowerCharger™ 4x4 to address common battery reliability issues. It is the first system in the industry to offer a complete and practical solution for improving the reliability, effectiveness, and cost of battery management.

1995

Receives ISO 9001 Certification, essential for marketing products in many European countries. This is an important endorsement of the quality of ZOLL's products and manufacturing practices.

Announces a distribution agreement covering ZOLL's products in Germany, the largest European market for resuscitation products.

Launches ZOLL 1600, the first fully upgradeable and configurable AED/manual external defibrillator. Small, light, and easy to use, the ZOLL 1600 is suitable for first responders, EMTs, and paramedics.

The U.S. Navy equips its major surface vessel hospitals and on-board medical facilities exclusively with the ZOLL PD 2000.

Introduces the first modular AC power supply/battery charger for hospital devices for use on the ZOLL 1400, 1600, and 2000 family of defibrillators.

1994

1992
Becomes a public company with an initial public offering of 2.1 million shares, which generates $14.6 million.

Releases the PD 1400 Pacemaker/Defibrillator/Monitor, the smallest and lightest device of its kind available for critical patient transport and pre-hospital treatment.

The American Heart Association elevates the importance of non-invasive pacing to the initial treatment of choice for certain serious patient conditions (Class 1 for profound bradycardia). ZOLL is the market leader for this technology.

The American Heart Association Guidelines strongly recommend, "defibrillators be immediately available to emergency personnel responding to a cardiac arrest," both in hospital and prehospital settings. It also emphasizes that the most important factor contributing to patient survival is the speed in delivering treatment.

1989
Introduces adult multi-function electrodes, which provide well-tolerated pacing, effective defibrillation, cardioversion, and monitoring—all through a single pair of pre-gelled disposable electrodes.

ZOLL Medical Corporation: An Innovator in Resuscitation

1988
Launches the ZOLL PD 1200™ Pacemaker/Defibrillator/Monitor, the first to combine proven pacing and defibrillating technology in a reliable, easy-to-use, compact unit. The operator can choose between monitoring, pacing, and defibrillation with just the turn of one control knob.

1986